Literature DB >> 31235265

Advances in the structural studies of antibiotic potentiators against Escherichia coli.

Gifty A Blankson1, Ajit K Parhi2, Malvika Kaul3, Daniel S Pilch4, Edmond J LaVoie5.   

Abstract

Entities:  

Year:  2019        PMID： 31235265      PMCID： PMC6650317          DOI： 10.1016/j.bmc.2019.06.003

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN： 0968-0896            Impact factor:   3.641


× No keyword cloud information.
  30 in total

1.  Inhibitors of efflux pumps in Pseudomonas aeruginosa potentiate the activity of the fluoroquinolone antibacterial levofloxacin.

Authors:  T E Renau; R Léger; E M Flamme; J Sangalang; M W She; R Yen; C L Gannon; D Griffith; S Chamberland; O Lomovskaya; S J Hecker; V J Lee; T Ohta; K Nakayama
Journal:  J Med Chem       Date:  1999-12-02       Impact factor: 7.446

2.  Addressing the stability of C-capped dipeptide efflux pump inhibitors that potentiate the activity of levofloxacin in Pseudomonas aeruginosa.

Authors:  T E Renau; R Léger; E M Flamme; M W She; C L Gannon; K M Mathias; O Lomovskaya; S Chamberland; V J Lee; T Ohta; K Nakayama; Y Ishida
Journal:  Bioorg Med Chem Lett       Date:  2001-03-12       Impact factor: 2.823

3.  The relationship between physicochemical properties, in vitro activity and pharmacokinetic profiles of analogues of diamine-containing efflux pump inhibitors.

Authors:  William J Watkins; Yakira Landaverry; Roger Léger; Renée Litman; Thomas E Renau; Nicole Williams; Rose Yen; Jason Z Zhang; Suzanne Chamberland; Deidre Madsen; David Griffith; Vrushali Tembe; Keith Huie; Michael N Dudley
Journal:  Bioorg Med Chem Lett       Date:  2003-12-01       Impact factor: 2.823

Review 4.  Bacterial efflux pump inhibition.

Authors:  Glenn W Kaatz
Journal:  Curr Opin Investig Drugs       Date:  2005-02

5.  Bacterial efflux systems and efflux pumps inhibitors.

Authors:  Béatrice Marquez
Journal:  Biochimie       Date:  2005-12       Impact factor: 4.079

Review 6.  Inhibitors of efflux pumps in Gram-negative bacteria.

Authors:  Jean-Marie Pagès; Muriel Masi; Jacques Barbe
Journal:  Trends Mol Med       Date:  2005-08       Impact factor: 11.951

7.  Synthesis of functionalized 2-aryl-5-nitro-1H-indoles and their activity as bacterial NorA efflux pump inhibitors.

Authors:  Siritron Samosorn; John B Bremner; Anthony Ball; Kim Lewis
Journal:  Bioorg Med Chem       Date:  2005-10-03       Impact factor: 3.641

8.  Peptidomimetics of efflux pump inhibitors potentiate the activity of levofloxacin in Pseudomonas aeruginosa.

Authors:  Thomas E Renau; Roger Léger; Rose Yen; Miles W She; Eric M Flamme; Joan Sangalang; Carla L Gannon; Suzanne Chamberland; Olga Lomovskaya; Ving J Lee
Journal:  Bioorg Med Chem Lett       Date:  2002-03-11       Impact factor: 2.823

9.  Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy.

Authors:  O Lomovskaya; M S Warren; A Lee; J Galazzo; R Fronko; M Lee; J Blais; D Cho; S Chamberland; T Renau; R Leger; S Hecker; W Watkins; K Hoshino; H Ishida; V J Lee
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

10.  Conformationally-restricted analogues of efflux pump inhibitors that potentiate the activity of levofloxacin in Pseudomonas aeruginosa.

Authors:  Thomas E Renau; Roger Léger; Lubov Filonova; Eric M Flamme; Michael Wang; Rose Yen; Deidre Madsen; David Griffith; Suzanne Chamberland; Michael N Dudley; Ving J Lee; Olga Lomovskaya; William J Watkins; Toshiharu Ohta; Kiyoshi Nakayama; Yohei Ishida
Journal:  Bioorg Med Chem Lett       Date:  2003-08-18       Impact factor: 2.823
View more
  3 in total

1.  Evaluation of a Conformationally Constrained Indole Carboxamide as a Potential Efflux Pump Inhibitor in Pseudomonas aeruginosa.

Authors:  Yongzheng Zhang; Jesus D Rosado-Lugo; Pratik Datta; Yangsheng Sun; Yanlu Cao; Anamika Banerjee; Yi Yuan; Ajit K Parhi
Journal:  Antibiotics (Basel)       Date:  2022-05-26

Review 2.  Synergy by Perturbing the Gram-Negative Outer Membrane: Opening the Door for Gram-Positive Specific Antibiotics.

Authors:  Charlotte M J Wesseling; Nathaniel I Martin
Journal:  ACS Infect Dis       Date:  2022-08-10       Impact factor: 5.578

3.  Evaluation of Heterocyclic Carboxamides as Potential Efflux Pump Inhibitors in Pseudomonas aeruginosa.

Authors:  Yi Yuan; Jesus D Rosado-Lugo; Yongzheng Zhang; Pratik Datta; Yangsheng Sun; Yanlu Cao; Anamika Banerjee; Ajit K Parhi
Journal:  Antibiotics (Basel)       Date:  2021-12-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.